These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 25138313)

  • 21. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.
    Biton Y; Goldenberg I; Kutyifa V; Baman JR; Solomon S; Moss AJ; Szepietowska B; McNitt S; Polonsky B; Zareba W; Barsheshet A
    J Am Coll Cardiol; 2016 Jan; 67(3):303-12. PubMed ID: 26796396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling.
    Goldstein RE; Haigney MC; Krone RJ; McNitt S; Zareba W; Moss AJ
    Heart Rhythm; 2013 Mar; 10(3):366-73. PubMed ID: 23183194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of ventricular arrhythmias in patients with cardiac resynchronization therapy without back-up ICD: a single-center experience.
    Bortnik M; Degiovanni A; Dell'era G; Cavallino C; Occhetta E; Marino P
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):301-6. PubMed ID: 23811840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic receptor gene polymorphism and left ventricular reverse remodelling after cardiac resynchronization therapy: preliminary results.
    Pezzali N; Curnis A; Specchia C; Carubelli V; Covolo L; Donato F; Auricchio A; Regoli F; Metra M
    Europace; 2013 Oct; 15(10):1475-81. PubMed ID: 23729404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction.
    Kutyifa V; Vermilye K; Solomon SD; McNitt S; Moss AJ; Daimee UA
    Eur J Heart Fail; 2019 Mar; 21(3):360-369. PubMed ID: 30592353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT.
    Slyngstad T; Huth Ruwald AC; Kutyifa V; McNitt S; Polonsky B; Solomon SD; Foster E; Goldenberg I; Wang PJ; Klein H; Zareba W; Moss AJ
    Heart Rhythm; 2014 Jun; 11(6):1001-7. PubMed ID: 24502968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular sphericity independently predicts appropriate implantable cardioverter-defibrillator therapy.
    Levine YC; Matos J; Rosenberg MA; Manning WJ; Josephson ME; Buxton AE
    Heart Rhythm; 2016 Feb; 13(2):490-7. PubMed ID: 26409099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D.
    Sebag FA; Lellouche N; Chen Z; Tritar A; O'Neill MD; Gill J; Wright M; Leclercq C; Rinaldi CA
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1368-75. PubMed ID: 25066404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis.
    Deif B; Ballantyne B; Almehmadi F; Mikhail M; McIntyre WF; Manlucu J; Yee R; Sapp JL; Roberts JD; Healey JS; Leong-Sit P; Tang AS
    Cardiovasc Res; 2018 Sep; 114(11):1435-1444. PubMed ID: 30010807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of 'super-responder' patients to cardiac resynchronization therapy.
    Zecchin M; Proclemer A; Magnani S; Vitali-Serdoz L; Facchin D; Muser D; Nordio A; Barbati G; Puggia I; Sinagra G; Proclemer A
    Europace; 2014 Mar; 16(3):363-71. PubMed ID: 24189477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).
    Brenyo A; Link MS; Barsheshet A; Moss AJ; Zareba W; Wang PJ; McNitt S; Huang D; Foster E; Estes M; Solomon SD; Goldenberg I
    J Am Coll Cardiol; 2011 Oct; 58(16):1682-9. PubMed ID: 21982313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors and outcomes of "super-response" to cardiac resynchronization therapy.
    Killu AM; Grupper A; Friedman PA; Powell BD; Asirvatham SJ; Espinosa RE; Luria D; Rozen G; Buber J; Lee YH; Webster T; Brooke KL; Hodge DO; Wiste HJ; Glikson M; Cha YM
    J Card Fail; 2014 Jun; 20(6):379-86. PubMed ID: 24632340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left Ventricular Reverse Remodeling in Cardiac Resynchronization Therapy and Long-Term Outcomes.
    Naqvi SY; Jawaid A; Vermilye K; Biering-Sørensen T; Goldenberg I; Zareba W; McNitt S; Polonsky B; Solomon SD; Kutyifa V
    JACC Clin Electrophysiol; 2019 Sep; 5(9):1001-1010. PubMed ID: 31537327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis.
    Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo Tcheugui JB; Martin DT; Joseph J; Singh JP
    Europace; 2021 Aug; 23(8):1262-1274. PubMed ID: 33496319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.